Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. It is available as a generic medication. Reference standards of Alendronate Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alendronate Sodium
Catalogue No.:PA 54 03000
CAS :
Molecular Formula : C4H12NNaO7P2
Molecular Weight : 271.08
Alendronate Sodium (1012780)
Catalogue No.:PA USP1012780
Molecular Formula : NA
Molecular Weight : NA
Sodium alendronate trihydrate (Y0001727)
Catalogue No.:PA EPY0001727
Sodium alendronate for system suitability (Y0001678)
Catalogue No.:PA EPY0001678
1-(Dimethoxyphosphoryl)-4-(1,3-dioxoisoindolin-2-yl)butyl dimethyl Phosphate
Catalogue No.:PA 54 0031000
Molecular Formula : C16H23NO9P2
Molecular Weight : 435.31
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
